Eli Lilly took part in the biopharmaceutical startup’s $155m series B while Weiqiao Pioneering led a $112m series A-plus round for robotic truck developer DeepWay.

A Man Holding a Blood Tube

Funding

US-based biopharmaceutical therapeutics developer ArriVent Biopharma raised $155m in series B funding from investors including pharmaceutical firm Eli Lilly’s regional fund, Lilly Asia Ventures. The round was co-led by Sofinnova Investments and General Catalyst and included Catalio Capital Management, HBM Healthcare Investments, Shanghai Healthcare Capital, Sequoia China, AIHC Capital, Terra Magnum Capital Partners, Unicorn Capital Partners Limited, Infinitum Asset Management, OrbiMed, Octagon Capital Advisors, Sirona Capital and Boyu/Zoo Capital.

Company Company description Sector Country Round Round size($m) Deal date Investors
DeepWay Smart commercial vehicle developer Transport China A+ 112 28/03/2023 Shandong Weiqiao Pioneering Group (lead), SoftBank (SB China Venture Capital); Qiming Venture Partners
Wellvana Health Healthcare delivery management platform Healthcare US N/A 84 27/03/2023 Heritage Group (lead), Memorial Hermann Health System; WCAS (Valtruis), Martin Ventures, First Trust Capital Partners, Adam Boehler
Salubris Biotherapeutics  Biologic therapeutics developer Healthcare China N/A 35 28/03/2023 Shenzhen Salubris Pharmaceuticals 
SolasCure Wound care gel developer Healthcare UK B 13.3 27/03/2023 Brain Biotech, Eva Pharma; Seneca Partners (lead), Jonathan Milner, Wealth Club
Mixergy Provider of home energy and heat storage systems Energy and Natural Resources UK N/A 11.3 27/03/2023 EDP (EDP Ventures) (lead), Centrica, Williams Advanced Engineering/Foresight Group (Foresight WAE Technology); Nesta, Oxford Science Enterprises, Kiko Ventures
EV Motors Japan Diversified electric vehicle and battery manufacturer Transport Japan C 11.1 (updated) 27/03/2023 NTT Docomo (NTT Docomo Ventures), Cygames (Cygames Capital), Shikoku Electric Power Company, JA Mitsui Leasing, Soei, Plus Ad Group, Morita, Restar Electronics, Iyo Bank (Iyogin Capital), Mitsubishi UFJ Trust and Banking Corporation, Fuyo General Lease, Kansai Electric Power (K4 Ventures), Kyuden Technosystems Corporation, Hankyu Bus, Sumitomo, Hibiki, Nishi-Nippon Railroad, Daiichi Kotsu, Wistron, Iyotetsu, IT-Farm, Mizuho Leasing, Sumitomo Mitsui Trust Bank, Yamanashi Chuo Bank (Yamanashi Chugin Management Consulting), Fukuoka Financial Group; Incubate Fund, Interwoos, Energy & Environment Investment, IMM Investment Corp (IMM Investment Group)
Nimbbl Ecommerce-focused checkout platform Financial India Pre-A 3.5 28/03/2023 Groww; Sequoia (Sequoia Capital India), Global Founders Capital 
Mamotest Developer of AI-based breast cancer diagnostics technology Healthcare Germany Pre-A 3.3 27/03/2023 Johnson & Johnson (Johnson & Johson Impact Ventures), Merck & Co; Sonen Capital, Sky High
Videowise Video commerce platform developer Consumer US Seed 3 27/03/2023 Slack (Slack Fund) (lead); FounderCollective, Underline Ventures, Mu Ventures, Ratio Ventures
Carbonaide Carbon dioxide-free concrete producer Industrial Finland Seed 1.9 28/03/2023 Lakan Betoni (co-lead), Vantaa Energy (co-lead)
GooPass (formerly Camelove) Camera equipment subscription service Consumer Japan C1 N/A 27/03/2023 Bic Camera, NTT Docomo (NTT Docomo Ventures), Sumitomo Mitsui Trust Bank/Panasonic (Sumitomo Mitsui Trust Panasonic Finance), Bank of Iwate (Iwagin Jigyo Souzou Capital)
Edison Fu

Edison Fu is head of Asia development at Global Corporate Venturing.